Safety and Efficacy Study of Pirfenidone to Treat Grade 2 or Above Radiation-induced Lung Injury

NCT02296281 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Radiation Pneumonitis

Interventions

DRUG: Pirfenidone

Sponsor

Beijing Continent Pharmaceutical Co, Ltd.

Collaborators

[object Object]
[object Object]